comment

1
19. Stein HJ, Feith M, Siewert JR: Approach to early Barrett’s cancer. World J Surg 2003;27:1040–1046. 20. Stein HJ, Sendler A, Fink U, et al.: Multidisciplinary approach to esophageal and gastric cancer. Surg Clin N Amer 2000;80:659– 682. 21. Fein M, Fuchs KH, Ritter MP, et al.: Application of the new clas- sification for cancer of the cardia. Surgery 1998;124:707–713. 22. Kodera Y, Yamamura Y, Shimizu Y, et al.: Adenocarcinoma of the gastroesophageal junction in Japan: Relevance of Siewert’s classification applied to 177 cases resected at a single institution. J Am Coll Surg 1999;189:594–601. 23. de Manzoni G, Pedrazzani C, Pasini F, et al.: Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg 2002;73:1035–1040. 24. Hardwick RH, Williams GT: Staging of oesophageal adenocarci- noma. Br J Surg 2002: 89:1076–1077. 25. Ichikura T, Ogawa T, Kawabata T, et al.: Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carci- noma? World J Surg 2003;27:334–338. 26. Stein HJ, von Rahden BHA, Ho ¨fler H, et al.: Karzinom des o ¨sophagogastralen U ¨ bergangs und Barrett O ¨ sophagus—ein nahezu klares onkologisches Modell? Chirurg 2003;74:703– 708. 27. Stein HJ, Feith M, Siewert JR: Cancer of the esophagogastric junction. Surg Oncol 2000: 9; 35–41. 28. Peracchia A, Bonavina L, Via A, et al.: Current trends in the surgical treatment of esophageal and cardia adenocarcinoma. J Exp Clin Cancer Res 1999;18:289–294. 29. Siewert JR, Stein HJ: Barrett’s cancer: Indications, extent and results of surgical resection. Semin Surg Oncol 1997;13:245– 252. 30. Sonett JR: Esophagectomy. The role of the intrathoracic anas- tomosis. Chest Surg Clin N Am 2000;10:519–530. 31. Hulscher JB, van Sandick JW, de Boer AG, et al.: Extended transthoracic resection compared with limited transhiatal resec- tion for adenocarcinoma of the esophagus. N Engl J Med 2002;21: 1662–1669. 32. Harrison LE, Karpeh MS, Brennan MF: Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998;123:127– 130. 33. Takeshita K, Saito N, Saeki I, et al.: Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: Surgical techniques and evaluation of postoperative function. Surgery 1997;121:278–286. 34. Papachristou DN, Fortner JG: Adenocarcinoma of the gastric cardia. The choice of gastrectomy. Ann Surg 1980;192:58–64. 35. Merendino KA, Dillard DH: The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiological abnormalities at the esophago–gastric junction. Ann Surg 1955; 142:486–506. COMMENT Professor Siewert and his colleagues have as extensive an experience with gastric cancer as any surgical group in the western world. It is fair to say that their series of 1,348 resected gastro-esophageal junction cancers is truly a gold mine for studying the nuances of the biology of the anatomic subsets of cancer in this location. This huge patient population, which they have studied so thoroughly and well, has given us some clear-cut answers to many intriguing questions, both biologic and therapeutic. Surgeons working in this area can now formulate treatment strategies, in regard to choice of esophagectomy and/or gastrectomy, with much more precision than before. Walter Lawrence, Jr., MD Guest Editor DOI 10.1002/jso.20219 Published online in Wiley InterScience (www.interscience.wiley.com). 146 Siewert et al. ß 2005 Wiley-Liss, Inc.

Upload: walter-lawrence

Post on 15-Jun-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

19. Stein HJ, Feith M, Siewert JR: Approach to early Barrett’s cancer.World J Surg 2003;27:1040–1046.

20. Stein HJ, Sendler A, Fink U, et al.: Multidisciplinary approach toesophageal and gastric cancer. Surg Clin N Amer 2000;80:659–682.

21. Fein M, Fuchs KH, Ritter MP, et al.: Application of the new clas-sification for cancer of the cardia. Surgery 1998;124:707–713.

22. Kodera Y, Yamamura Y, Shimizu Y, et al.: Adenocarcinoma of thegastroesophageal junction in Japan: Relevance of Siewert’sclassification applied to 177 cases resected at a single institution.J Am Coll Surg 1999;189:594–601.

23. de Manzoni G, Pedrazzani C, Pasini F, et al.: Results of surgicaltreatment of adenocarcinoma of the gastric cardia. Ann ThoracSurg 2002;73:1035–1040.

24. Hardwick RH, Williams GT: Staging of oesophageal adenocarci-noma. Br J Surg 2002: 89:1076–1077.

25. Ichikura T, Ogawa T, Kawabata T, et al.: Is adenocarcinoma of thegastric cardia a distinct entity independent of subcardial carci-noma? World J Surg 2003;27:334–338.

26. Stein HJ, von Rahden BHA, Hofler H, et al.: Karzinom desosophagogastralen Ubergangs und Barrett Osophagus—einnahezu klares onkologisches Modell? Chirurg 2003;74:703–708.

27. Stein HJ, Feith M, Siewert JR: Cancer of the esophagogastricjunction. Surg Oncol 2000: 9; 35–41.

28. Peracchia A, Bonavina L, Via A, et al.: Current trends in thesurgical treatment of esophageal and cardia adenocarcinoma.J Exp Clin Cancer Res 1999;18:289–294.

29. Siewert JR, Stein HJ: Barrett’s cancer: Indications, extent andresults of surgical resection. Semin Surg Oncol 1997;13:245–252.

30. Sonett JR: Esophagectomy. The role of the intrathoracic anas-tomosis. Chest Surg Clin N Am 2000;10:519–530.

31. Hulscher JB, van Sandick JW, de Boer AG, et al.: Extendedtransthoracic resection compared with limited transhiatal resec-tion for adenocarcinoma of the esophagus. N Engl J Med 2002;21:1662–1669.

32. Harrison LE, Karpeh MS, Brennan MF: Total gastrectomy is notnecessary for proximal gastric cancer. Surgery 1998;123:127–130.

33. Takeshita K, Saito N, Saeki I, et al.: Proximal gastrectomy andjejunal pouch interposition for the treatment of early cancer in theupper third of the stomach: Surgical techniques and evaluation ofpostoperative function. Surgery 1997;121:278–286.

34. Papachristou DN, Fortner JG: Adenocarcinoma of the gastriccardia. The choice of gastrectomy. Ann Surg 1980;192:58–64.

35. Merendino KA, Dillard DH: The concept of sphincter substitutionby an interposed jejunal segment for anatomic and physiologicalabnormalities at the esophago–gastric junction. Ann Surg 1955;142:486–506.

COMMENT

Professor Siewert and his colleagues have as extensivean experience with gastric cancer as any surgical group inthe western world. It is fair to say that their series of 1,348resected gastro-esophageal junction cancers is truly a goldmine for studying the nuances of the biology of theanatomic subsets of cancer in this location. This hugepatient population, which they have studied so thoroughlyand well, has given us some clear-cut answers to many

intriguing questions, both biologic and therapeutic.Surgeons working in this area can now formulate treatmentstrategies, in regard to choice of esophagectomy and/orgastrectomy, with much more precision than before.

Walter Lawrence, Jr., MD

Guest Editor

DOI 10.1002/jso.20219

Published online in Wiley InterScience (www.interscience.wiley.com).

146 Siewert et al.

� 2005 Wiley-Liss, Inc.